Rodney D. Sinclair

Grattan Street
Parkville, VIC 3010, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 318 publications

Upadacitinib for Severe Alopecia Areata in Adults and Adolescents: Two Phase 3 UP-AA Randomized Clinical Trials.

Upadacitinib for Severe Alopecia Areata in Adults and Adolescents: Two Phase 3 UP-AA Randomized Clinical Trials.

Journal: JAMA dermatology

Published: August 12, 2026

Simulating real-world abrocitinib use in atopic dermatitis: results from JADE REAL.

Simulating real-world abrocitinib use in atopic dermatitis: results from JADE REAL.

Journal: The Journal of dermatological treatment

Published: August 07, 2026

Correction: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.

Correction: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.

Journal: American journal of clinical dermatology

Published: June 18, 2026

Development of a Core Outcome Domain Set for Facial Aging.

Development of a Core Outcome Domain Set for Facial Aging.

Journal: JAMA dermatology

Published: June 17, 2026

Congenital Hypotrichosis with Hair and Dental Ectodermal Features Responsive to Sublingual Minoxidil.

Congenital Hypotrichosis with Hair and Dental Ectodermal Features Responsive to Sublingual Minoxidil.

Journal: Clinical and experimental dermatology

Published: March 03, 2026

Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges - A Narrative Review.

Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges - A Narrative Review.

Journal: Journal of inflammation research

Published: February 18, 2026

Treatment of androgenetic alopecia in transgender people receiving testosterone therapy with sublingual minoxidil: A randomized, double-blind, placebo-controlled clinical trial.

Treatment of androgenetic alopecia in transgender people receiving testosterone therapy with sublingual minoxidil: A randomized, double-blind, placebo-controlled clinical trial.

Journal: Journal of the American Academy of Dermatology

Published: January 31, 2026

How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach.

How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach.

Journal: Dermatology and therapy

Published: January 27, 2026

Hair Transplant Donor Site Associated Hair Neogenesis: Quantitative Trichoscopy Results.

Hair Transplant Donor Site Associated Hair Neogenesis: Quantitative Trichoscopy Results.

Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]

Published: December 18, 2025

Description of the Tranquillo Phase 3 Clinical Trial Designs/Study Protocols to Assess Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo.

Description of the Tranquillo Phase 3 Clinical Trial Designs/Study Protocols to Assess Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo.

Journal: Dermatology and therapy

Published: December 15, 2025

Outcome measure instruments for the assessment and treatment of androgenetic alopecia: A scoping review.

Outcome measure instruments for the assessment and treatment of androgenetic alopecia: A scoping review.

Journal: Clinical and experimental dermatology

Published: December 05, 2025

Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia-Pacific Modified Delphi Expert Panel Recommendations.

Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia-Pacific Modified Delphi Expert Panel Recommendations.

Journal: International journal of dermatology

Published: December 01, 2025

Showing 1-12 of 318

Last Updated: 09/26/2026